4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001193125-26-038007
President and CEO sold 3,745 shares at $0.98 ($3,655)
- President and CEO acquired 10,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shukla Sanjay · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-03 | Exercise or conversion : show line 1 in the form | +10,375 | 157,298 | D | ||
| 2026-02-04 | Sale : show line 2 in the form | −3,745 | $0.98 | $3,655 | 153,553 | D |
| Open-market sales · 3,745 sh · avg $0.98 · $3,655 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-03 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −10,375 | 0 | D |
Loading xslF345X05/ownership.xml…